A research team has successfully demonstrated the world’s first gene-editing treatment for Leber’s hereditary optic neuropathy (LHON). The study was conducted in collaboration with the Seoul National University College of Veterinary Medicine and Edgene Co., Ltd.
This article was originally published on MedicalXpress.com

